4//SEC Filing
Fortress Biotech, Inc. 4
Accession 0001429260-26-000004
$FBIOCIK 0001644963operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:05 PM ET
Size
5.4 KB
Accession
0001429260-26-000004
Insider Transaction Report
Form 4
Fortress Biotech, Inc.
10% Owner
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2026-01-02+111,209→ 439,733 total
Footnotes (1)
- [F1]The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. 111,209 shares were granted by the Issuer to the reporting Person for the 2025 annual dividend.
Documents
Issuer
AVENUE THERAPEUTICS, INC.
CIK 0001644963
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001429260
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:05 PM ET
- Size
- 5.4 KB